Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

145 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Incidence of cancer after a first episode of idiopathic venous thromboembolism treated with 3 months or 1 year of oral anticoagulation.
Taliani MR, Agnelli G, Prandoni P, Becattini C, Moia M, Bazzan M, Ageno W, Tomasi C, Guazzaloca G, Ambrosio GB, Bertoldi A, Salvi R, Poggio R, Silingardi M; Warfarin Optimal Duration Italian Trial (WODIT) Investigators. Taliani MR, et al. Among authors: moia m. J Thromb Haemost. 2003 Aug;1(8):1730-3. doi: 10.1046/j.1538-7836.2003.00293.x. J Thromb Haemost. 2003. PMID: 12911585 Free article.
Thrombophilic abnormalities and recurrence of venous thromboembolism in patients treated with standardized anticoagulant treatment.
Santamaria MG, Agnelli G, Taliani MR, Prandoni P, Moia M, Bazzan M, Guazzaloca G, Ageno W, Bertoldi A, Silingardi M, Tomasi C, Ambrosio GB; Warfarin Optimal Duration Italian Trial (WODIT) Investigators. Santamaria MG, et al. Among authors: moia m. Thromb Res. 2005;116(4):301-6. doi: 10.1016/j.thromres.2004.12.012. Epub 2005 Jan 26. Thromb Res. 2005. PMID: 16038714
Duration of anticoagulant treatment and recurrence of venous thromboembolism in patients with and without thrombophilic abnormalities.
Taliani MR, Becattini C, Agnelli G, Prandoni P, Moia M, Bazzan M, Salvi R, Ageno W, Guazzaloca G, Imberti D, Silingardi M, Poggio R; Warfarin Optimal Duration Italian Trial (WODIT) Investigators. Taliani MR, et al. Among authors: moia m. Thromb Haemost. 2009 Mar;101(3):596-8. Thromb Haemost. 2009. PMID: 19277429 No abstract available.
Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators.
Agnelli G, Prandoni P, Santamaria MG, Bagatella P, Iorio A, Bazzan M, Moia M, Guazzaloca G, Bertoldi A, Tomasi C, Scannapieco G, Ageno W; Warfarin Optimal Duration Italian Trial Investigators. Agnelli G, et al. Among authors: moia m. N Engl J Med. 2001 Jul 19;345(3):165-9. doi: 10.1056/NEJM200107193450302. N Engl J Med. 2001. PMID: 11463010 Free article. Clinical Trial.
Aspirin for preventing the recurrence of venous thromboembolism.
Becattini C, Agnelli G, Schenone A, Eichinger S, Bucherini E, Silingardi M, Bianchi M, Moia M, Ageno W, Vandelli MR, Grandone E, Prandoni P; WARFASA Investigators. Becattini C, et al. Among authors: moia m. N Engl J Med. 2012 May 24;366(21):1959-67. doi: 10.1056/NEJMoa1114238. N Engl J Med. 2012. PMID: 22621626 Free article. Clinical Trial.
145 results